Welcome to CDC stacks | Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada - 56921 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada
  • Published Date:
    Jul 2018
  • Source:
    Emerg Infect Dis. 24(7):1267-1274.
  • Language:
    English
Filetype[PDF-394.32 KB]


Details:
No Related Documents.
You May Also Like: